Drug:
Reaction: DEATH
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940065 |
EU |
2 | |
Death, Product use issue, |
||||
TECLISTAMAB-CQYV, DARATUMUMAB, |
||||
| 2 | 26940066 |
US |
2 | |
Death, |
||||
OLAPARIB, |
||||
| 3 | 26940076 |
IN |
75 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 4 | 26940093 |
CA |
1 | |
Death, |
||||
UPADACITINIB, |
||||
| 5 | 26940113 |
UY |
58 | 2 |
Death, |
||||
UPADACITINIB, |
||||
| 6 | 26940133 |
MY |
2 | |
Death, |
||||
OSIMERTINIB, |
||||
| 7 | 26940147 |
IN |
65 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 8 | 26940165 |
US |
1 | |
Death, |
||||
AZILSARTAN KAMEDOXOMIL, |
||||
| 9 | 26940215 |
US |
2 | |
Death, |
||||
EVOLOCUMAB, |
||||
| 10 | 26940291 |
EU |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 11 | 26940298 |
SV |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 12 | 26940510 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 13 | 26940536 |
US |
1 | |
Death, |
||||
| 14 | 26940586 |
US |
2 | |
Death, Lung carcinoma cell type unspecified stage IV, |
||||
OSIMERTINIB, |
||||
| 15 | 26940683 |
BR |
||
Death, |
||||
LENALIDOMIDE, |
||||
| 16 | 26940698 |
CA |
55 | 1 |
Death, Pulmonary embolism, Metastases to abdominal cavity, Diarrhoea, Nausea, Abdominal distension, |
||||
TRIPTORELIN PAMOATE, TRIPTORELIN PAMOATE, |
||||
| 17 | 26940759 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 18 | 26940769 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 19 | 26940840 |
EU |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 20 | 26940949 |
HK |
1 | |
Death, |
||||
| 21 | 26941004 |
CA |
98 | 1 |
Death, |
||||
FARICIMAB, |
||||
| 22 | 26941045 |
US |
1 | |
Death, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 23 | 26941087 |
EU |
||
Death, |
||||
RILPIVIRINE, CABOTEGRAVIR, |
||||
| 24 | 26941092 |
CN |
1 | |
Death, |
||||
DURVALUMAB, |
||||
| 25 | 26941093 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 26 | 26941236 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 27 | 26941338 |
IN |
1 | |
Death, |
||||
DURVALUMAB, |
||||
| 28 | 26941346 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 29 | 26941351 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 30 | 26941367 |
EU |
65 | 2 |
Death, Drug effective for unapproved indication, Unintentional use for unapproved indication, Off label use, Therapy change, |
||||
EFGARTIGIMOD ALFA, EFGARTIGIMOD ALFA, EFGARTIGIMOD ALFA, EFGARTIGIMOD ALFA, |
||||
| 31 | 26941369 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 32 | 26941433 |
JP |
||
Death, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 33 | 26941456 |
JP |
7 | 1 |
Death, Pain, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 34 | 26941534 |
EU |
||
Death, |
||||
ECULIZUMAB, |
||||
| 35 | 26941578 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 36 | 26941633 |
EU |
80 | 1 |
Death, |
||||
EMICIZUMAB, |
||||
| 37 | 26941643 |
US |
90 | 1 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 38 | 26941658 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 39 | 26941698 |
EU |
2 | |
Death, |
||||
ADALIMUMAB, |
||||
| 40 | 26941743 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 41 | 26941778 |
CN |
||
Death, |
||||
RITUXIMAB, |
||||
| 42 | 26941781 |
US |
77 | 1 |
Death, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, CYCLOBENZAPRINE, GABAPENTIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ESCITALOPRAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, FUROSEMIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ALLOPURINOL, CAMPHOR, MENTHOL, COUGH SUPPRESSANT, 2%MENTHOL, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MUPIROCIN, MUPIROCIN CALCIUM, PANTOPRAZOLE, |
||||
| 43 | 26941862 |
EU |
1 | |
Death, |
||||
ADALIMUMAB, |
||||
| 44 | 26941937 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 45 | 26941984 |
US |
76 | 1 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 46 | 26941985 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 47 | 26942015 |
MX |
||
Death, |
||||
OBINUTUZUMAB, |
||||
| 48 | 26942170 |
US |
83 | 2 |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 49 | 26942189 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 50 | 26942221 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 51 | 26942231 |
US |
||
Death, Impaired gastric emptying, Ileus, Pancreatitis necrotising, |
||||
ORAL SEMAGLUTIDE, |
||||
| 52 | 26942248 |
VN |
1 | |
Death, |
||||
ACALABRUTINIB, |
||||
| 53 | 26942267 |
US |
2 | |
Death, |
||||
RAVULIZUMAB, |
||||
| 54 | 26942288 |
IN |
1 | |
Death, |
||||
| 55 | 26942293 |
PR |
72 | 1 |
Death, |
||||
LENALIDOMIDE, |
||||
| 56 | 26942347 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 57 | 26942356 |
GB |
70 | 2 |
Death, |
||||
| 58 | 26942374 |
US |
90 | 2 |
Death, |
||||
CERTOLIZUMAB PEGOL, FOLIC ACID, SERTRALINE HYDROCHLORIDE, |
||||
| 59 | 26942376 |
CA |
85 | 1 |
Death, |
||||
| 60 | 26942406 |
US |
1 | |
Death, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 61 | 26942459 |
US |
74 | |
Death, |
||||
LENALIDOMIDE, |
||||
| 62 | 26942486 |
1 | ||
Death, |
||||
LENALIDOMIDE, |
||||
| 63 | 26942499 |
CA |
72 | 1 |
Death, Lung neoplasm malignant, Fall, Pneumonia, Respiratory distress, Pneumonitis, Asthma, Oedema peripheral, Impaired healing, |
||||
MEPOLIZUMAB, OMALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE INHALATION SPRAY, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 64 | 26942511 |
EU |
62 | 1 |
Death, Cerebral haemorrhage, Coma, |
||||
UPADACITINIB, |
||||
| 65 | 26942535 |
CA |
70 | 2 |
Death, Squamous cell carcinoma of the oral cavity, Off label use, Product ineffective for unapproved use, |
||||
ACITRETIN, UPADACITINIB, HYDROXYCHLOROQUINE, SECUKINUMAB, HUMAN IMMUNOGLOBULIN G, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, SULFASALAZINE, |
||||
| 66 | 26942548 |
US |
82 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 67 | 26942570 |
IN |
60 | |
Death, Pneumonia, Multiple organ dysfunction syndrome, Pain, Gastrointestinal infection, Product use in unapproved indication, |
||||
NINTEDANIB ESYLATE, |
||||
| 68 | 26942600 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 69 | 26942624 |
VE |
1 | |
Death, |
||||
| 70 | 26942652 |
TH |
58 | 2 |
Death, |
||||
ADO-TRASTUZUMAB EMTANSINE, |
||||
| 71 | 26942664 |
CA |
||
Death, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 72 | 26942667 |
FJ |
1 | |
Death, |
||||
| 73 | 26942939 |
US |
2 | |
Death, |
||||
POLYVINYL ALCOHOL, POVIDONE, |
||||
| 74 | 26943029 |
US |
85 | 1 |
Death, Hypotension, Somnolence, Feeling abnormal, |
||||
TREPROSTINIL, TREPROSTINIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NERANDOMILAST, VIBEGRON, TAMSULOSIN HYDROCHLORIDE, ALBUTEROL SULFATE, NINTEDANIB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ROPINIROLE, GABAPENTIN, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE AND ALBUTEROL, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, FUROSEMIDE, LEVALBUTEROL TARTRATE, CETIRIZINE HCL, CETIRIZINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 75 | 26943052 |
US |
69 | 2 |
Death, |
||||
DIROXIMEL FUMARATE, |
||||
| 76 | 26943087 |
US |
85 | 2 |
Death, |
||||
NATALIZUMAB, |
||||
| 77 | 26943210 |
82 | 1 | |
Death, Hypersensitivity, |
||||
CETUXIMAB, |
||||
| 78 | 26943273 |
48 | 2 | |
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 79 | 26943276 |
76 | 2 | |
Death, |
||||
TEMOZOLOMIDE, |
||||
| 80 | 26943277 |
87 | 1 | |
Death, |
||||
ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, |
||||
| 81 | 26943297 |
US |
58 | 2 |
Death, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 82 | 26943309 |
US |
60 | 1 |
Death, |
||||
ZONGERTINIB, THYROID, PORCINE, ERGOCALCIFEROL, |
||||
| 83 | 26943375 |
US |
54 | 2 |
Death, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, DENOSUMAB, |
||||
| 84 | 26943406 |
IN |
||
Death, Product use in unapproved indication, |
||||
NINTEDANIB ESYLATE, |
||||
| 85 | 26943417 |
AR |
1 | |
Death, |
||||
SECUKINUMAB, |
||||
| 86 | 26943425 |
1 | ||
Death, |
||||
SOTORASIB, |
||||
| 87 | 26943475 |
US |
1 | |
Death, |
||||
ABALOPARATIDE, TOCILIZUMAB-AAZG, |
||||
| 88 | 26943488 |
31 | 2 | |
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 89 | 26943537 |
US |
74 | 2 |
Death, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 90 | 26943570 |
US |
||
Death, |
||||
GIVOSIRAN SODIUM, GIVOSIRAN SODIUM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DOFETILIDE, GABAPENTIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, VALSARTAN, VALSARTAN ORAL, ERGOCALCIFEROL, |
||||
| 91 | 26943689 |
US |
37 | 1 |
Death, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 92 | 26943695 |
|||
Death, Blood creatinine increased, |
||||
ACYCLOVIR, LORAZEPAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 93 | 26943697 |
|||
Death, Thrombocytopenia, |
||||
LINEZOLID, LINEZOLID, CLOFAZIMINE, |
||||
| 94 | 26943719 |
KR |
70 | 2 |
Death, Rectosigmoid cancer metastatic, |
||||
FRUQUINTINIB, |
||||
| 95 | 26943733 |
2 | ||
Death, |
||||
QUIZARTINIB, |
||||
| 96 | 26943816 |
1 | ||
Death, |
||||
INSULIN LISPRO, |
||||
| 97 | 26943829 |
US |
1 | |
Death, |
||||
ONABOTULINUMTOXINA, |
||||
| 98 | 26943867 |
GB |
1 | |
Death, |
||||
CLOZAPINE, |
||||
| 99 | 26943876 |
IN |
67 | 1 |
Death, Suspected off label use, |
||||
| 100 | 26943892 |
MA |
2 | |
Death, |
||||
PALBOCICLIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30